Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Danne

Showing results (41-50 of 186) with videos related to

Pageof 19
Sort By:
Journal of Clinical Epidemiology|November 16, 2016
Time-to-event methodology improved statistical evaluation in register-based health services researchTobias Bluhmki, Peter Bramlage, Michael Volk, et al.
Diabetes, Obesity & Metabolism|October 18, 2021
The automated pancreas: A review of technologies and clinical practiceTorben Biester, Martin Tauschmann, Agata Chobot, et al.
Pediatric Diabetes|August 31, 2012
Recommendations for age-appropriate education of children and adolescents with diabetes and their parents in the European UnionDelphine Martin, Karin Lange, Alexandra Sima, et al.
Diabetes, Obesity & Metabolism|June 10, 2020
Lower risk of severe hypoglycaemia with insulin glargine 300 U/mL versus glargine 100 U/mL in participants with type 1 diabetes: A meta-analysis of 6-month phase 3 clinical trialsThomas Danne, Munehide Matsuhisa, Christian Sussebach, et al.
Diabetes Care|August 27, 2005
Pharmacokinetics, prandial glucose control, and safety of insulin glulisine in children and adolescents with type 1 diabetesThomas Danne, Reinhard H A Becker, Tim Heise, et al.
Diabetes Technology & Therapeutics|January 19, 2017
"Let the Algorithm Do the Work": Reduction of Hypoglycemia Using Sensor-Augmented Pump Therapy with Predictive Insulin Suspension (SmartGuard) in Pediatric Type 1 Diabetes PatientsTorben Biester, Olga Kordonouri, Martin Holder, et al.
Diabetes, Obesity & Metabolism|April 19, 2017
Effects of dapagliflozin on insulin-requirement, glucose excretion and ß-hydroxybutyrate levels are not related to baseline HbA1c in youth with type 1 diabetesTorben Biester, Baerbel Aschemeier, Maryam Fath, et al.
Pediatric Diabetes|January 23, 2019
The rate of hyperglycemia and ketosis with insulin degludec-based treatment compared with insulin detemir in pediatric patients with type 1 diabetes: An analysis of data from two randomized trialsNandu Thalange, Larry Deeb, Georgeanna Klingensmith, et al.
BMJ Open Diabetes Research & Care|February 9, 2017
Determinants of weight change in patients on basal insulin treatment: an analysis of the DIVE registryPeter Bramlage, Tobias Bluhmki, Holger Fleischmann, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|August 2, 2021
Telemonitoring, Telemedicine and Time in Range During the Pandemic: Paradigm Change for Diabetes Risk Management in the Post-COVID FutureThomas Danne, Catarina Limbert, Manel Puig Domingo, et al.
Pageof 19

Showing results (41-50 of 186) with videos related to

Sort By:
Pageof 19
Journal of Clinical Epidemiology|November 16, 2016
Time-to-event methodology improved statistical evaluation in register-based health services researchTobias Bluhmki, Peter Bramlage, Michael Volk, et al.
Diabetes, Obesity & Metabolism|October 18, 2021
The automated pancreas: A review of technologies and clinical practiceTorben Biester, Martin Tauschmann, Agata Chobot, et al.
Pediatric Diabetes|August 31, 2012
Recommendations for age-appropriate education of children and adolescents with diabetes and their parents in the European UnionDelphine Martin, Karin Lange, Alexandra Sima, et al.
Diabetes, Obesity & Metabolism|June 10, 2020
Lower risk of severe hypoglycaemia with insulin glargine 300 U/mL versus glargine 100 U/mL in participants with type 1 diabetes: A meta-analysis of 6-month phase 3 clinical trialsThomas Danne, Munehide Matsuhisa, Christian Sussebach, et al.
Diabetes Care|August 27, 2005
Pharmacokinetics, prandial glucose control, and safety of insulin glulisine in children and adolescents with type 1 diabetesThomas Danne, Reinhard H A Becker, Tim Heise, et al.
Diabetes Technology & Therapeutics|January 19, 2017
"Let the Algorithm Do the Work": Reduction of Hypoglycemia Using Sensor-Augmented Pump Therapy with Predictive Insulin Suspension (SmartGuard) in Pediatric Type 1 Diabetes PatientsTorben Biester, Olga Kordonouri, Martin Holder, et al.
Diabetes, Obesity & Metabolism|April 19, 2017
Effects of dapagliflozin on insulin-requirement, glucose excretion and ß-hydroxybutyrate levels are not related to baseline HbA1c in youth with type 1 diabetesTorben Biester, Baerbel Aschemeier, Maryam Fath, et al.
Pediatric Diabetes|January 23, 2019
The rate of hyperglycemia and ketosis with insulin degludec-based treatment compared with insulin detemir in pediatric patients with type 1 diabetes: An analysis of data from two randomized trialsNandu Thalange, Larry Deeb, Georgeanna Klingensmith, et al.
BMJ Open Diabetes Research & Care|February 9, 2017
Determinants of weight change in patients on basal insulin treatment: an analysis of the DIVE registryPeter Bramlage, Tobias Bluhmki, Holger Fleischmann, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|August 2, 2021
Telemonitoring, Telemedicine and Time in Range During the Pandemic: Paradigm Change for Diabetes Risk Management in the Post-COVID FutureThomas Danne, Catarina Limbert, Manel Puig Domingo, et al.
Pageof 19